Capricor Therapeutics
CAPR
CAPR
21 hedge funds and large institutions have $3.01M invested in Capricor Therapeutics in 2017 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0.03% less ownership
Funds ownership: 0.45% → 0.42% (-0.03%)
Holders
21
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$209K | |
| 2 | +$169K | |
| 3 | +$90K | |
| 4 |
BlackRock
New York
|
+$65K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$58K |
Top Sellers
| 1 | -$448K | |
| 2 | -$189K | |
| 3 | -$60K | |
| 4 |
Morgan Stanley
New York
|
-$50.6K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$38K |